» Authors » M Yliskoski

M Yliskoski

Explore the profile of M Yliskoski including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 44
Citations 406
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Halmesmaki K, Hurskainen R, Teperi J, Grenman S, Kivela A, Kujansuu E, et al.
BJOG . 2007 Apr; 114(5):563-8. PMID: 17439564
Objective: To compare among women with menorrhagia the effect of hysterectomy or levonorgestrel-releasing intrauterine system (LNG-IUS) on sexual functioning. Design: A randomised controlled trial. Setting: Five university hospitals in Finland....
2.
Halmesmaki K, Hurskainen R, Tiitinen A, Teperi J, Grenman S, Kivela A, et al.
Hum Reprod . 2004 Jan; 19(2):378-82. PMID: 14747185
Background: The purpose of this study was to compare the effects of hysterectomy and a levonorgestrel-releasing intrauterine system (LNG-IUS) on serum FSH levels and menopausal symptoms. Methods: A total of...
3.
Inki P, Hurskainen R, Palo P, Ekholm E, Grenman S, Kivela A, et al.
Ultrasound Obstet Gynecol . 2002 Oct; 20(4):381-5. PMID: 12383322
Objective: To analyze the effect of the levonorgestrel-releasing intrauterine system (LNG-IUS) on ovarian cyst formation, endometrial thickness and the size of uterus and uterine fibroids by ultrasonography. Subjects And Methods:...
4.
Hurskainen R, Aalto A, Teperi J, Grenman S, Kivela A, Kujansuu E, et al.
BJOG . 2001 Apr; 108(3):281-5. PMID: 11281469
Objective: To discover whether psychosocial factors can explain why many women with normal menstrual blood loss seek care for menorrhagia. Design: Cross-sectional comparative study of women referred for menorrhagia. Setting:...
5.
Hurskainen R, Teperi J, Rissanen P, Aalto A, Grenman S, Kivela A, et al.
Lancet . 2001 Feb; 357(9252):273-7. PMID: 11214131
Background: Heavy menstrual blood loss is a common reason for women to seek medical care. The levonorgestrel-releasing intrauterine system (IUS) is an effective medical treatment for menorrhagia. We report a...
6.
Kurvinen K, Yliskoski M, Saarikoski S, Syrjanen K, Syrjanen S
Eur J Cancer . 2000 Jul; 36(11):1402-10. PMID: 10899654
Expression of the human papillomavirus (HPV) E6 and E7 oncogenes is regulated on the transcriptional level by specific protein-binding sites contained in the viral long control region (LCR). Sequence changes...
7.
Hurskainen R, Teperi J, Turpeinen U, Grenman S, Kivela A, Kujansuu E, et al.
Acta Obstet Gynecol Scand . 1998 Mar; 77(2):201-4. PMID: 9512328
Background: To develop an objective measurement system for menstrual blood loss applicable in clinical practice. Methods: One hundred and fifty-six patients were enrolled in a randomized trial of the treatment...
8.
Ji H, Yliskoski M, Anttila M, Syrjanen K, Saarikoski S
Int J Gynaecol Obstet . 1996 Jul; 54(1):37-44. PMID: 8842816
Objective: To evaluate the surgical management and outcome of stage-I borderline ovarian tumors. Methods: A series of 95 cases of FIGO stage-I borderline ovarian tumors was retrospectively reviewed. Results: The...
9.
Syrjanen K, Nurmi T, Mantyjarvi R, Ilonen J, Syrjanen S, Surcel H, et al.
Cytopathology . 1996 Apr; 7(2):99-107. PMID: 9074659
Certain genotypes of HPV have been recently implicated in the etiology of carcinoma of the uterine cervix. In order to determine whether HLA antigen-controlled immunoregulatory functions have a role in...
10.
Puranen M, Yliskoski M, Saarikoski S, Syrjanen K, Syrjanen S
Am J Obstet Gynecol . 1996 Feb; 174(2):694-9. PMID: 8623809
Objective: The purpose of this study was to determine the potential for human papillomavirus to be transmitted vertically. Study Design: We started a systematic study of children 0.3 to 11.6...